STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation.

[1]  T. Graf,et al.  Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages , 2000 .

[2]  B. Löwenberg,et al.  STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27Kip1 , 2000, Oncogene.

[3]  Matthew B. Wilson,et al.  Control of myeloid differentiation and survival by Stats , 2000, Oncogene.

[4]  J. Grandis,et al.  STAT signaling in head and neck cancer , 2000, Oncogene.

[5]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[6]  L. Kobari,et al.  Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[8]  D. Link,et al.  A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation. , 1999, Immunity.

[9]  I. Touw,et al.  Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia–derived Mutation in the G-CSF Receptor Gene , 1999, The Journal of experimental medicine.

[10]  L. Hennighausen,et al.  Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. , 1998, Journal of immunology.

[11]  A. Nienhuis,et al.  Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells , 1998, Nature Medicine.

[12]  D. Link,et al.  Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. , 1998, The Journal of clinical investigation.

[13]  B. Löwenberg,et al.  Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. , 1998, Blood.

[14]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[15]  F. Gouilleux,et al.  Activated Stat related transcription factors in acute leukemia. , 1997, Leukemia & lymphoma.

[16]  C. Quilici,et al.  Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. , 1997, Blood.

[17]  T. Hirano,et al.  Involvement of STAT3 in the Granulocyte Colony-stimulating Factor-induced Differentiation of Myeloid Cells* , 1997, The Journal of Biological Chemistry.

[18]  D. Link,et al.  Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. , 1997, Blood.

[19]  Richard J Smeyne,et al.  Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. , 1997, Blood.

[20]  J. Cowland,et al.  Granules of the human neutrophilic polymorphonuclear leukocyte. , 1997, Blood.

[21]  C. Scott,et al.  Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. , 1997, Blood.

[22]  S. Akira,et al.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Höglund,et al.  Effects of in vivo administration of G–CSF on neutrophil functions in healthy volunteers , 1997, European journal of haematology.

[24]  B. Druker,et al.  Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils. , 1997, Experimental hematology.

[25]  D. Link,et al.  Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. , 1996, Immunity.

[26]  D. Tweardy,et al.  Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. , 1996, Blood.

[27]  J. Gabrilove,et al.  Filgrastim (r-metHuG-CSF): the first 10 years. , 1996, Blood.

[28]  B. Avalos,et al.  Molecular analysis of the granulocyte colony-stimulating factor receptor. , 1996, Blood.

[29]  T. Hirano,et al.  A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells. , 1996, The EMBO journal.

[30]  T. Ley,et al.  Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3 , 1996, Molecular and cellular biology.

[31]  L. Hoefsloot,et al.  The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. , 1996, Blood.

[32]  S. Narula,et al.  The effect of GM-CSF and G-CSF on human neutrophil function. , 1995, Immunopharmacology.

[33]  C. Hack,et al.  Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. , 1994, Blood.

[34]  A R Dunn,et al.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. , 1994, Blood.

[35]  P. Lamb,et al.  Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor , 1994 .

[36]  L. Hoefsloot,et al.  Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation , 1993, Molecular and cellular biology.

[37]  S. Nagata,et al.  Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor , 1993, Cell.

[38]  S. Ziegler,et al.  Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction , 1993, Molecular and cellular biology.

[39]  H. Tsumura,et al.  Mutant protein of recombinant human granulocyte colony-stimulating factor for receptor binding assay. , 1991, Analytical biochemistry.

[40]  A Howell,et al.  The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  N. Nicola,et al.  Binding of 125I‐labeled granulocyte colony‐stimulating factor to normal murine hemopoietic cells , 1985, Journal of cellular physiology.

[42]  M. Wigler,et al.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Yoshimura,et al.  The Jak-Stat pathway in normal and perturbed hematopoiesis. , 2000, Blood.

[44]  I. Touw,et al.  Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. , 1999, Blood.

[45]  M. Cascio,et al.  Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. , 1999, Blood.

[46]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[47]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[48]  D. Tweardy,et al.  Stat3 and G-CSF-induced myeloid differentiation. , 1998, Leukemia & lymphoma.

[49]  G. Carulli.  Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions. , 1997, Haematologica.